The price trend for BRIACELL THERAP (BCTX) has been bearish lately and the stock has lost 28.2% over the past week. However, the formation of a hammer chart pattern in its last trading session ...

BRIACELL THERAP (BCTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

View BriaCell Therapeutics Corp BCTX stock quote prices, financial information, real-time forecasts, and company news from CNN.

BRIACELL THERAP (BCTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

On Wednesday, BriaCell Therapeutics (NASDAQ:BCTX) stock traded higher with a session volume of 113.08 million, compared to the average volume of 366.19 thousand, according to data from Benzinga Pro.

BriaCell Therapeutics Corp. (NASDAQ:BCTX) confirmed on Thursday that it has sustained a complete resolution of the lung metastasis, first reported in February 2025, two months after the initial ...

BriaCell Therapeutics Corp. Annual stock financials by MarketWatch. View the latest BCTX financial statements, income statements and financial ratios.